NCT02603835 - Evaluation of Intracoronary Hyperoxemic Oxygen Therapy in Anterior Acute Myocardial Infarction Patients (IC-HOT) | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

August 31, 2017

Study Completion Date

May 17, 2018

Conditions

Anterior Wall Acute Myocardial Infarction

Interventions

DEVICE

SSO2 Therapy

Delivery of SSO2 Therapy for 60 minutes selectively into the left main coronary artery (LMCA) using the TherOx DownStream System along with a single use disposable device called the TherOx DownStream Cartridge and a commercially available, qualified SSO2 delivery catheter

Trial Locations (15)

17011

Holy Spirit Cardiology, Camp Hill

17822

Geisinger Medical Center, Danville

18101

Lehigh Valley Hospital, Allentown

27610

WakeMed Heart Center, Raleigh

35801

Heart Center, Inc., Huntsville

37660

Wellmont CVA Heart Institute, Kingsport

48073

Beaumont Hospital, Royal Oak

48075

Providence-Providence Park Hospital, Southfield

48202

Henry Ford Medical Center, Detroit

48236

St. John Hospital & Medical Center, Detroit

60007

Alexian Brothers Heart & Vascular Institute, Elk Grove Village

92037

Scripps Hospital, La Jolla

06801

Danbury Hospital, Danbury

01199

Baystate Medical Center, Springfield

02906

The Miriam Hospital/Rhode Island Hospital, Providence